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Nonaromatic Triazoles
A Base-Controlled Reaction of 2-Cyanoacetamidines
(3,3-Diaminoacrylonitriles) with Sulfonyl Azides as a Route to
Nonaromatic 4-Methylene-1,2,3-triazole-5-imines
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Vasiliy A. Bakulev[a]
Abstract: Reactions of 2-cyanoacetamidines with sulfonyl
azides were shown to take place via two different pathways to
form a mixture of 1-substituted 5-amino-1,2,3-triazoles 3 and
novel 4-methylene-1H-1,2,3-triazole-5(4H)-imine derivatives 4–
14. In the absence of a base, 5-amino-1,2,3-triazoles 3 are
formed as the only products. The presence of 1.2 equiv. of so-
dium ethoxide or DBU switches the reaction outcome while
involving the cyano group, resulting (after a 1,5-protic shift) in
Introduction
Since the beginning of this millennium, 1,2,3-triazoles have be-
come very fashionable and rather available compounds due to
the landmark discovery of copper catalyzed alkyne azide cyclo-
addition (CuAAC)[1] giving access to various types of 1,2,3-tri-
azoles and facilitating their use in medicinal chemistry,[2] in or-
ganic synthesis as building blocks,[3] in chemical biology,[4] and
in material chemistry.[5] Apart from the CuAAC reaction, the
transformation of functionalized hydrazones,[6] the reactions of
azides with enamines,[7] and carbonyl active methylene com-
pounds,[6,8] reactions of NH-1,2,3-triazoles with electrophiles,[6,9]
intra-[10] and intermolecular reactions of diazo compounds with
aldimines,[6] and transformations of other heterocyclic com-
pounds[11] are the main synthetic methods towards 1,2,3-tri-
azoles of various structures. However, these methods are not
applicable to the synthesis of 1,2,3-triazoles bearing both
sulfonylamido and amidino groups which are of interest for me-
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triazoles 4–14 as the only products. The methods were elabo-
rated for the selective and efficient synthesis of triazoles 3 and
4-methylene-1,2,3-triazole-5-imines 4–14 including one-pot
synthesis from sodium azide and sulfonyl chlorides. The
unusual structure of 4–14 compounds was confirmed by X-ray
data and 2D 1H–15N and 1H–13C NMR spectra. The formation
of the products was explained by the presence of two strong
hydrogen bonds N···H and O···H in these molecules.
dicinal chemistry.[12] Hence, the search of new effective meth-
ods for the synthesis of variously substituted 1,2,3-triazoles
remains a subject worthy of investigation. Because a few 5-
amino-1,2,3-triazole derivatives were synthesized from the reac-
tion of 2-ethoxycarbonylacetamidines[10] and from malonodi-
nitrile with benzenesulfonyl azide[13] we turned our attention
to the reactivity of 2-cyanoacetamidines towards sulfonyl azides
to prepare derivatives of 5-amino-1,2,3-triazole-4-carbimid-
amides (Scheme 1).
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It is worth noting that in contrast to the well-studied 2-cyan-
othioacetamides,[11a,14] the chemistry of their aza analogs, 2-
cyanoacetamidines is poorly described in the literature[15] and
their reactions with azides presented in only one report.[15e]
It was shown there that the formation of intermediate diazo
compounds took place as a result of diazo group transfer
(Regitz reaction), which then cyclized to 5-amino-1,2,3-triazole-
4-carbonitriles (Scheme 1). The generally accepted opinion on
the single diazo group transfer direction of methylene active
amidines with sulfonyl azides has been held for the long
time.[16,20]
Combined experimental and theoretical studies of the reac-
tion of amidines 1 with azides 2 have now demonstrated two
different pathways for this reaction, leading to 5-amino-4-
cyano-1,2,3-triazoles 3 and novel 5-sulfonylimido-4-methylene-
1,2,3-triazoles 4–14 (Scheme 1). Depending on the presence
and amount of base used, the direction of the reaction can be
switched in favor of either compound. Thus, proper conditions
were found and methods were elaborated for the selective and
efficient synthesis of 4-cyano-5-cycloamino-1,2,3-triazoles 3 and
4-methylene-1,2,3-triazole-5-imines 4–14 (Scheme 1). The path-
way to triazoles 4–14 represents a novel method of the synthe-
sis of 1,2,3-triazoles based on tandem heterocyclization of 2-
cyanoacetamidines and sulfonyl azides to 1-sulfonyl-1,2,3-tri-
azoles and their subsequent rearrangement followed by a 1,5-
protic shift to form the final products.
Results and Discussion
Usually, reactions of active methylene compounds with azides
take place in the presence of various bases.[11a,17,18] In this work,
we have found that 2-cyanoacetamidines 1 can react with
mesyl azide even in the absence of an external base to form
4-cyanotriazoles 3 confirming the Regitz diazo-group-transfer
course for this reaction.[18] The use of mesyl azide allows to
easily separate the triazoles 3 from the by-product, mesyl amide
by washing out the latter with water. It should be noted that
mesyl azide is potentially explosive, and all reactions should
be carried out behind blast shields. At the more available and
considerably less expensive than 2-morpholinoethylsulfonyl az-
ide which has been used previously[15e] to prepare compounds
3. Furthermore, the LCMS analysis of the sample 3a showed,
next to same time, mesyl azide is the major products 3a the
presence of a very small impurity of triazole 4a.
In order to study the use of 2-cyanoacetamidine as a C–C–
C–N building block and to involve the CN group in the process
leading to 4-methylene-1,2,3-triazole-5-imines from sulfonyl
azides, we screened the reaction conditions using 3-(azepane-
1-yl)-3-iminopropanenitrile (1a) and 4-fluorobenzenesulfonyl
azide 2a as model reagents (Table 1 and Table SI1 of Support-
ing Info). Our initial optimization studies revealed the fact that
depending on the presence and amount of base used, the di-
rection of the reaction can be switched in favor of either prod-
uct. In the absence of a base or in the presence of weak bases
triazole 3a is formed as major product. As it is seen from the
Table 1 the use of strong bases, low temperature favor the for-
mation of triazole 4a. The optimal conditions for the synthesis
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of the target compound 4a include the use of ethanol as a
solvent, 1.2 equiv. of a sodium ethoxide, and a temperature of
–10 °C. The use of DBU in either 1,4-dioxane or benzene gives
a slightly less yield of 4a and can be considered an alternative
protocol of the synthesis of compounds 4 (Table 1, Supporting
Info, Table S1).
Table 1. Optimization of the reaction conditions for the synthesis of triazole
4a.[a]
Entry T, °C Solvent Base Time Ratio Isolated
[min] 4a/3a yield, 4a [%]
1 r.t. EtOH (95 %) – 30 2:98 –
2 r.t. EtOH (95 %) Et3N 30 17:83 –
3 r.t. EtOH (95 %) DBU 30 69:31 –
4 r.t. EtOH (anh.) EtONa[e] 30 92:8 87[f]
5[c] r.t. EtOH (anh.) EtONa[e] 30 95:5 89[f]
6 r.t. iPrOH (anh.) iPrONa[e] 30 94:6 89[f]
7 r.t. 1,4-dioxane DBU 30 95:5 90[f]
8[b] –10 EtOH (anh.) EtONa[e] 30 99:1 93[f]
9[d] r.t. 1,4-dioxane DBU 30 – 91[f]
[a] Unless noted, 1a (0.1 mmol), 2a (0.1 mmol), base (100 mol-%) in the
solvent (0.4 mL) at the indicated temperature for the time given. Ratio 4:3 in
mixtures estimated by 19F NMR spectra for compound 4a and FBSA (concen-
tration of 4a and FBSA are always equal). [b] Base (120 mol-%). [c] Base
(200 mol-%). [d] 1a (1.0 mmol), 2a (1.0 mmol) in the solvent (4 mL). [e] Was
used as freshly prepared solution from sodium and anhydrous alcohol. [f ]
Isolated yield after crystallization from ethanol.
Encouraged by these results, we used these optimized reac-
tion conditions for the reactions of tertiary 2-cyanoacet-
amidines 1a–f with sulfonyl azides 2a–f. Their structures are
shown in Scheme 2. We have shown that all amidines 1
smoothly react with azides 2 to form a series of 33 compounds
4–14 (Scheme 3).
The reaction tolerates different tertiary amine moieties in
amidine group of compounds 1 and 4-substituents in the aryl
of the arylsulfonyl azides 2. However, in contrast to other com-
pounds, the yields of 1,2,3-triazoles 4e–8e bearing a 4-nitro-
benzenesulfonyl group are only moderate (31–38 %). Fortu-
nately, the use of DBU in 1,4-dioxane allowed us to obtain these
compounds in high yields. Triazoles 14a–c bearing methyl-
sulfonimido group were also prepared by alternative protocol.
The formation of triazoles 4 took place with retention of all the
reagent atoms and therefore can be referred to as an atom
economic process, to be used for the design of a new green
chemistry process. Thus, we have elaborated a general method
for the synthesis of novel 5-sulfonylimino-1H-1,2,3-triazole-
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Scheme 2. The structures of starting reagents used in this study.
ous tertiary methylenediamine moieties and sulfonylimino
groups in good to excellent yields (mainly 80–95 %) (Scheme 3).
Based on our knowledge that the reaction of sulfonyl azides
2 with 2-cyanoacetamidines 1 is leading to selective formation
of triazoles 4–14, to show the practical convenience of the de-
veloped method we tried to synthesize these compounds in a
Scheme 3. Synthesis of triazole-4-carbonitriles 3 and triazoles 4–14.[a] Reaction condition: amidine 1 (1.0 mmol), sodium (28 mg, 1.2 mmol), anhydrous
ethanol (4 mL), +10 °C, 5–10 min → azide 2 (1.0 mmol), –10 °C, 1 h. [b] Isolated yields. [c] With DBU (1.0 mmol) as the base, 1,4-dioxane (4 mL) as the solvent
at room temperature for 10 min.
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one-pot protocol starting from arylsulfonyl chlorides 2′a,c, so-
dium azide and 2-cyanoacetamidines 1a, b, e (Table 2). Sulfonyl
chlorides 2′ in EtOH were converted with sodium azide to the
sulfonyl azides, which were then treated with an ethanol-alkali
mixture of the corresponding amidine 1. After workup with
water and acetic acid pure triazoles 4a, c, 5a, c and 8a, c could
be filtered off in 80–88 % yield (Table 2). Table 2 demonstrates
that the yields of triazoles 4, 5, 8 using the one-pot procedure
are higher than the protocol involving the isolation of sulfonyl
azides 2. Thus, a convenient effective one-pot protocol for the
synthesis of triazoles 4, 5, 8 from readily available starting
reagents was elaborated. The method also allows to avoid iso-
lating the potentially explosive sulfonyl azides, increasing the
safety.
NMR and HRMS of compounds 4–14 are consistent with the
proposed structure. Similar to other NH-triazoles, the 1H NMR
spectra of these compounds contain the signals of the NH pro-
ton downfield in the range of 13.85–14.29 ppm. Based on the
1H–13C 2D NMR spectra of 11 we identified the signals of C4
and C5 of 1,2,3-triazole ring at 117–119.5 and 146.1–147.7 ppm,
respectively. They are different from those for aromatic 5-sulfon-
amido-1,2,3-triazole which contain both signals in a narrow
range of 131.6–139 ppm,[14a] allowing to exclude the tautomer
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Table 2. The yields of triazoles 4a,c, 5a,c, 8a,c according to the one-pot protocol[a] compared to the yields involving isolation of azides.
Entry ArSO2Cl, 2′ Amidine, 1 Product Yields of triazoles, %
Ar one-pot synthesis with isolation of azide 2
1 4-FC6H4 (2′a) 1a 4a 80 79
2 4-FC6H4 (2′a) 1b 5a 88 81
3 4-FC6H4 (2′a) 1e 8a 85 81
4 Tolyl (2′c) 1a 4c 88 80
5 Tolyl (2′c) 1b 5c 87 81
6 Tolyl (2′c) 1e 8c 88 80
[a] 1) 2′ (1.00 mmol), NaN3 (1.05 mmol), EtOH (2 mL), r.t., 24 h. 2) 1 (0.90 mmol), Na (1.08 mmol), EtOH (2 mL), 0 °C, 0.5 h.
The final prove of structure of 4–14 in the solid state was
made based on X-ray analysis for monocrystals of triazoles 4c,
5b, 7c (Figures S1–S3 of Supporting Info), and in the solution
the confirmation came from HSQC and HMBC 1H–15N 2D NMR
spectra of 5c where there are cross peaks of the signals of both
protons of the NH2 group with the signal of 15N (Supporting
Info).
The quantum chemical evaluation (DFT wB97XD/ccpvtz) of
the relative thermodynamic stability and bond lengths of all
possible tautomeric forms of compound 5b are shown in Fig-
ure 1.
The calculated bond lengths are close to those determined
by X-ray analysis for the 5b tautomer. Data of calculated ener-
gies showed that tautomer 5b with the exocyclic C=C bond is
more stable than all other tautomers by more than 5 kcal/mol
(Figure 1).
The unexpectedly high thermodynamic stability of the non-
aromatic isomer 5b compared to its aromatic tautomers is due
to two very strong hydrogen bonds, N···H (1.854 Å) and O···H
(2.059 Å). A tentative mechanism for the formation of com-
Figure 1. Relative free energies (kcal/mol) and the bond lengths [Å] of triazoles 5b,5b1,5b2,5b3 (bond lengths according RSA are in parentheses).
Eur. J. Org. Chem. 2020, 3688–3698 www.eurjoc.org © 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim3691
pounds 3–14 is depicted in Scheme 4. We propose that the
triazenyl anion I1 generated by the addition of sulfonyl azide 2
to the carbanion formed after deprotonation of 1 is a common
intermediate of the pathways leading to products 3–14. The
cyclization of anion I1 onto the cyano group leading to triazol-
idine I2 (route a), and 1,4-prototropic shift in I1 leading to diazo
compound I6 (route b)[14] are competitive reactions. Cyclization
of diazoimines I6 via heteroelectrocyclic[19] ring closure occurs
to give final triazoles 3.
Alternatively addition of sulfonamide anion onto cyano
group and protonation of the latter by reaction by protic me-
dium affords 1,2,3-triazoline I2. We propose that triazoline I2
easily transforms in basic solution to aromatic triazole I3, and
this is in agreement with the isolation of stable 5-amino-1-aryl-
1,2,3-triazole-4-carbonitriles in reactions of malonodinitrile with
arylazides.[17] Then rearrangement of triazole I3, bearing strong
withdrawing sulfonyl group destabilizing the ring,[20] can un-
dergoes by either Dimroth type or double Cornforth type re-
sulting triazole I5 which are well known in the 1,2,3-triazole
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Scheme 4. A plausible mechanism for the formation of compounds 3–14.
be intra- or intermolecular sulfonyl transfer similar to the report
of Watanabe et al.[21] The final step includes unprecedented 1,5-
protropic shift for 1-sulfonylamino-3-iminopropenes leading to
products 4–14.
Conclusion
In conclusion, an effective and flexible approach to functional-
ized 1,2,3-triazoles from 2-cyanoacetamidines and sulfonyl
azides is described. The variation of the type of a solvent and
base allowed using the 2-cyanoacetamidines either as C–C–N
or C–C building blocks to form NH-1,2,3-triazoles 3 and 4–14,
respectively, from the same reagents. The use of 1.2 equiv. of
sodium ethoxide in ethanol or in other alcohols and use of DBU
in either 1,4-dioxane of benzene changes the direction of the
reaction, allowing the construction of novel 5-sulfonylimido-4-
methylene-1,2,3-triazoles 4–14 as the only products. This dra-
matic redirection of the reaction course is explained by a plausi-
ble mechanism: a common intermediate triazenide-anion re-
sulting from cyanoacetamidine and sulfonyl azides undergoes
either 1,4-prototropic shift followed by 1,5-cyclization or cycliza-
tion of azide involving the cyano group to form triazoles 3 or
4–14, respectively. The unusual structure of compounds 4–14
is rationalized by the presence of two hydrogen bonds N···H
and O···H in these molecules.
Experimental Section
General: Starting materials and reagents were purchased from
commercial sources and used without further purification. Ethanol
was dried and distilled from CaO and magnesium shavings corre-
spondingly prior to use. 1H and 13C NMR spectra were recorded at
400 and 100 MHz, respectively, with SiMe4 as internal reference in
[D6]DMSO, the chemical shifts (δ) were expressed in ppm, and J
values were given in Hz. High-resolution mass spectra (HRMS) were
obtained via electrospray ionization source (ESI). The IR spectra
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were recorded with a FT-IR ATR (attenuated total reflection, ZnSe)
spectrometer in the 4000–500 cm–1 region. The reactions were
monitored by analytical TLC on Sorbfil UV-254 aluminum foil plates
with 0.2 mm silica gel with a fluorescent indicator visualized under
UV light. Melting points were determined on Stuart SMP10 melting
point apparatus and are uncorrected.
Preparation of Amidines: Amidines 1b–f were synthesized from
ethyl 2-cyanoacetimidate and corresponding amines according to
the literature procedures.[22,15e]
Preparation of Sulfonyl Azides: Sulfonyl azides 2a–f were pre-
pared from the corresponding sulfonyl chlorides[23] following the
literature procedures. Warning! Sulfonyl azides are potentially explo-
sive, and all reactions should be carried out behind blast shields.
We recommend the use of plastic spatulas for the handling of solid
material.
(E)-3-Amino-3-(azepane-1-yl)acrylonitrile (1a):[24] A solution of
ethyl 2-cyanoacetimidate (6.08 g, 54.3 mmol) and azepane (5.37 g,
54.3 mmol) in anhydrous EtOH (54 mL) was stirred at ambient tem-
perature for 24 h. Then the solution was kept in a cold place for
3 h. The formed precipitate was filtered off and washed with dry
Et2O to give 1a as a colorless solid; m.p. 109–110 °C (lit.[22] 108–
109 °C (PhH)). 1H NMR (400 MHz, [D6]DMSO): δ = 1.44–1.50 (m, 4H),
1.62 (br. s, 4H), 2.87 (s, 1H), 3.26–3.29 (m, 4H), 5.45 (br. s, 1H). 13C
NMR (100 MHz, [D6]DMSO): δ = 26.2 (2C), 27.3 (2C), 37.3 (2C), 48.1,
124.3, 161.8.
General Procedure for the Synthesis of Triazole-4-carbonitriles
3: Mesyl azide (2f ) (121 mg, 1.0 mmol) was added to the solution
of amidine 1 (1.0 mmol) in ethanol (4–8 mL) and the resulting mix-
ture was stirred at room temperature (at 50 °C for 3d) for 30 min.
Then the solvent was removed under reduced pressure and water
(4 mL) was added to the residue. The resulting suspension was
heated at reflux for 1 min and then cooled to room temperature.
The precipitate was filtered off, washed with water, dried and crys-
tallized from ethanol or DCM.
5-(Azepane-1-yl)-1H-1,2,3-triazole-4-carbonitrile (3a):[15e] Com-
pound 3a was obtained in 96 % yield (366 mg) according to the
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252 mg, 2.0 mmol; ethanol (8 mL)) as a colorless solid; m.p. 175–
176 °C (DCM) (lit.[15e] 174–175 °C). 1H NMR (400 MHz, [D6]DMSO):
δ = 1.44–1.54 (m, 4H, 2CH2), 1.66–1.76 (m, 4H, 2CH2), 3.43–3.54 (m,
4H, 2CH2), 14.78 (br. s, 1H, NH). 13C NMR (100 MHz, [D6]DMSO): δ =
26.4 (CH2), 27.4 (CH2), 49.7 (CH2), 99.6 (C4), 115.2 (CN), 151.0 (C5).
5-(Pyrrolidin-1-yl)-1H-1,2,3-triazole-4-carbonitrile (3b):[15e]
Compound 3b was obtained in 94 % yield (153 mg) according to
the general procedure (amidine 1b: 137 mg, 1.0 mmol; azide 2f:
121 mg, 1.0 mmol; ethanol (4 mL)) as a colorless solid; m.p. 217–
219 °C (ethanol) (lit.[15e] 219–220 °C). 1H NMR (400 MHz, [D6]DMSO):
δ = 1.94 (br. s, 4H, 2CH2), 3.40 (br. s, 4H, 2CH2), 14.81 (br. s, 1H, NH).
13C NMR (100 MHz, [D6]DMSO): δ = 25.0 (CH2), 48.7 (CH2), 100.0
(C4), 115.1 (CN), 149.6 (C5).
5-(Piperidin-1-yl)-1H-1,2,3-triazole-4-carbonitrile (3c):[15e] Com-
pound 3c was obtained in 91 % yield (161 mg) according to the
general procedure (amidine 1c: 151 mg, 1.0 mmol; azide 2f: 121 mg,
1.0 mmol; ethanol (4 mL)) as a colorless solid; m.p. 180–183 °C
(DCM) (lit.[15e] 180–181 °C). 1H NMR (400 MHz, [D6]DMSO): δ = 1.57–
1.62 (m, 6H, 3CH2), 3.34–3.41 (m, 4H, 2CH2), 15.03 (br. s, 1H, NH).
13C NMR (100 MHz, [D6]DMSO): δ = 23.1 (CH2), 24.3 (2CH2), 48.5
(2CH2), 102.4 (C4), 114.6 (CN), 153.4 (C5).
5-(4-Benzylpiperidin-1-yl)-1H-1,2,3-triazole-4-carbonitrile
(3d):[15e] Compound 3d was obtained in 93 % yield (247 mg) ac-
cording to the general procedure (amidine 1d: 241 mg, 1.0 mmol;
azide 2f: 121 mg, 1.0 mmol; ethanol (4 mL) as a colorless solid; m.p.
172–174 °C (DCM) (lit. [1 5e ] 173–174 °C). 1H NMR (400 MHz,
[D6]DMSO): δ = 1.23–1.33 (m, 2H, CH2), 1.64–1.67 (m, 2H, CH2), 1.70–
1.80 (m, 1H, CH), 2.51–2.58 (m, 2H, CH2), 2.94–2.99 (m, 2H, CH2),
3.80 (d, J = 12.0 Hz, 2H, CH2Ph), 7.16–7.20 (m, 3H, Ph), 7.26–7.30 (m,
2H, Ph), 15.00 (br. s, 1H, NH). 13C NMR (100 MHz, [D6]DMSO): δ =
30.2 (CH2), 36.2 (CH), 41.7 (CH2Ph), 47.8 (CH2), 102.7 (C4), 114.3 (CN),
125.6 (Cp–), 127.9 (Co–), 128.8 (Cm–), 139.7 (Ci–), 153.5 (C5).
5-Morpholino-1H-1,2,3-triazole-4-carbonitrile (3e):[15e] Com-
pound 3e was obtained in 96 % yield (171 mg) according to the
general procedure (amidine 3e: 153 mg, 1.0 mmol; azide 2f:
121 mg, 1.0 mmol; ethanol (4 mL)) as a colorless solid; m.p. 206–
207 °C (DCM) (lit.[15e] 207–208 °C). 1H NMR (400 MHz, [D6]DMSO):
δ = 3.30–3.39 (m, 4H, 2CH2), 3.68–3.79 (m, 4H, 2CH2), 15.14 (br. s,
1H, NH). 13C NMR (100 MHz, [D6]DMSO): δ = 47.5 (CH2), 65.2 (CH2),
103.4 (C4), 114.3 (CN), 154.6 (C5).
General Procedure for the Synthesis of Triazoles 4–14
Method A: Amidine 1 (1.0 mmol) was added into a solution of
sodium ethoxide, cooled to +10 °C, freshly prepared from sodium
(28 mg, 1.2 mmol) and anhydrous ethanol (4 mL), and the resulting
mixture was stirred at +10 °C for a further 5–10 min. Then the
reaction mixture was cooled to –10 °C and the corresponding azide
2 (1.0 mmol) was added to the reaction mixture and the resulting
mixture were stirred at –10 °C for 1 h. The solvent was removed
under reduced pressure, the residue was dissolved in water (4 mL)
and acetic acid was added (72 mg, 1.2 mmol). The formed precipi-
tate was filtered off, washed with water, purified by crystallization
from ethanol and dried in a desiccator over P4O10.
Method B: DBU (152 mg, 1.0 mmol) was added to the solution of
amidine 1 (1.0 mmol) in 1,4-dioxane (4 mL) at room temperature
was stirred for 5 min and then azide 2 (1.0 mmol) was added. The
reaction mixture was stirred for 10 min at room temperature, then
glacial acetic acid (0.6–0.8 mL) was added and the resulting solution
was stirred for 15 min more. Then water (15 mL) was added to the
reaction mixture, formed precipitate was filtered off, washed with
water and dried in a desiccator over P4O10.
Eur. J. Org. Chem. 2020, 3688–3698 www.eurjoc.org © 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim3693
Method C: A mixture of sulfonyl chloride 2′ (1.00 mmol) and NaN3
(68.25 mg, 1.05 mmol) was stirred in ethanol (2 mL) for 24 h at
room temperature. Ethanol-alkali mixture of corresponding amidine
1, prepared from ethanol (2 mL), Na (25 mg, 1.08 mmol) and amid-
ine 1 (0.9 mmol) was added to the reaction mixture at 0° C, and
the resulting suspension was stirred at 0 °C for 30 min. Then water
(10 mL) and glacial acid (0.8 mL) were added to the reaction mix-
ture. Formed precipitate was filtered off, washed with water and
dried in a desiccator over P4O10.
N-((4Z,5Z)-5-(Amino(azepane-1-yl)methylene)-3,5-dihydro-4H-
1,2,3-triazol-4-ylidene)fluorobenzenesulfonamide (4a): Com-
pound 4a was obtained in 93 % yield (340 mg) according to the
general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1a:
165 mg, 1.0 mmol; azide 2a: 201 mg, 1.0 mmol; ethanol (4 mL)) as
a colorless solid; m.p. 185–186 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 1.53 (br. s, 4H), 1.77 (br. s, 4H), 3.61 (br. s, 2H), 4.21 (br. s, 2H),
7.27 (t, J = 9.0 Hz, 2H), 7.88 (dd, J = 9.0, 5.4 Hz, 2H), 8.19 (br. s, 1H),
8.54 (br. s, 1H), 14.18 (br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ =
25.1, 25.8, 25.9, 28.2, 50.0, 51.8, 115.4 (d, J = 22 Hz), 118.6, 128.4 (d,
J = 9 Hz), 141.1 (d, J = 3 Hz), 146.9, 155.2, 163.2 (d, J = 248 Hz). IR
(ATR, ZnSe, cm–1): ν 3313, 3171, 3110, 2935, 2857, 1650, 1587, 1550,
1368, 1219, 1043, 935. HRMS (ESI-TOF) m/z calcd. for C15H20FN6O2S
[M + H]+: 367.1347, found 367.1356.
Compound 4a was obtained in 80 % yield (263.5 mg) according to
the general procedure C (4-fluorobenzenesulfonyl chloride (2′a):
194 mg, 1.0 mmol; NaN3: 68.3 mg, 1.05 mmol; amidine 1a:
148.5 mg, 0.9 mmol; Na: 25 mg, 1.08 mmol, EtOH (4 mL)) as a
colorless solid; m.p. 185–186 °C.
N-((4Z,5Z)-5-(Amino(azepane-1-yl)methylene)-3,5-dihydro-4H-
1,2,3-triazol-4-ylidene)benzenesulfonamide (4b): Compound 4b
was obtained in 86 % yield (299 mg) according to the general pro-
cedure A (sodium: 28 mg, 1.2 mmol; amidine 1a: 165 mg, 1.0 mmol;
azide 2b: 183 mg, 1.0 mmol; ethanol (4 mL)) as a colorless solid;
m.p. 198–199 °C. 1H NMR (400 MHz, [D6]DMSO): δ = 1.53 (br. s, 4H),
1.76 (br. s, 4H), 3.60 (m, 2H), 4.22 (br. s, 2H), 7.41–7.48 (m, 3H), 7.81–
7.86 (m, 2H), 8.17 (br. s, 1H), 9.60 (br. s, 1H), 14.17 (br. s, 1H). 13C
NMR (100 MHz, [D6]DMSO): δ = 25.0, 25.7, 25.9, 28.2, 50.0, 51.7,
118.3, 125.5, 128.4, 130.7, 144.7, 147.0, 155.2. IR (ATR, ZnSe, cm–1):
ν 3301, 3110, 2922, 2853, 1652, 1591, 1554, 1124, 1084, 994. HRMS




pound 4c was obtained in 89 % yield (322 mg) according to the
general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1a:
165 mg, 1.0 mmol; azide 2c: 197 mg, 1.0 mmol; ethanol (4 mL)) as
a colorless solid; m.p. 231–232 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 1.53 (br. s, 4H), 1.77 (br. s, 4H), 2.31 (s, 3H), 3.60 (br. s, 2H), 4.23
(br. s, 2H), 7.24 (d, J = 8.3 Hz, 2H), 7.71 (d, J = 8.3 Hz, 2H), 8.15 (br.
s, 1H), 9.63 (br. s, 1H), 14.12 (br. s, 1H). 13C NMR (100 MHz,
[D6]DMSO): δ = 20.7, 25.1, 25.7, 25.9, 28.2, 50.0, 51.7, 118.1, 125.6,
128.8, 140.6, 141.8, 147.0, 155.1. IR (ATR, ZnSe, cm–1): ν 3272, 3147,
2930, 1658, 1594, 1542, 1134, 1084, 930. HRMS (ESI-TOF) m/z calcd.
for C16H23N6O2S: [M + H]+: 363.1598, found 363.1602.
Compound 4c was obtained in 88 % yield (287 mg) according to
the general procedure C (4-methylbenzenesulfonyl chloride (2′c):
190 mg, 1.0 mmol; NaN3: 68.3 mg, 1.05 mmol; amidine 1a:
148.5 mg, 0.9 mmol; Na: 25 mg, 1.08 mmol, EtOH (4 mL)) as a
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pound 4d was obtained in 92 % yield (345 mg) according to the
general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1a:
165 mg, 1.0 mmol; azide 2d: 213 mg, 1.0 mmol; ethanol (4 mL)) as
a colorless solid; m.p. 190–191 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 1.52 (br. s, 4H), 1.77 (br. s, 4H), 3.60 (br. s, 2H), 3.77 (s, 3H), 4.24
(br. s, 2H), 6.97 (d, J = 9.0 Hz, 2H), 7.77 (d, J = 9.0 Hz, 2H), 8.14 (br.
s, 1H), 9.66 (br. s, 1H), 14.11 (br. s, 1H). 13C NMR (100 MHz,
[D6]DMSO): δ = 25.1, 25.8, 25.9, 28.2, 50.0, 51.7, 55.3, 113.6, 118.0,
127.5, 136.7, 147.0, 155.1, 161.0. IR (ATR, ZnSe, cm–1): ν 3257, 3150,
3075, 2940, 1594, 1567, 1496, 1244, 1083, 1031, 908. HRMS (ESI-TOF)
m/z calcd. for: [M + H]+: C16H23N6O3S 379.1547, found 379.1557.
N-((4Z,5Z)-5-(Amino(azepane-1-yl)methylene)-3,5-dihydro-4H-
1,2,3-triazol-4-ylidene)nitrobenzenesulfonamide (4e): Com-
pound 4e was obtained in 38 % yield (149 mg) according to the
general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1a:
165 mg, 1.0 mmol; azide 2e: 228 mg, 1.0 mmol; ethanol (4 mL)) as
a light yellow solid; m.p. 258–259 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 1.45–1.60 (m, 4H), 1.66–1.86 (m, 4H), 3.50–3.73 (m, 2H), 4.00–
4.22 (m, 2H), 8.04 (d, J = 9.0 Hz, 2H), 8.28 (d, J = 9.0 Hz, 3H), 9.33
(br. s, 1H), 14.37 (br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ = 25.0,
25.6, 26.0, 28.1, 49.9, 51.7, 119.5, 123.9, 127.0, 146.0, 148.5, 150.6,
155.5. IR (ATR, ZnSe, cm–1): ν 3211, 3160, 2944, 1662, 1605, 1558,
1520, 1342, 1088, 958. HRMS (ESI-TOF) m/z calcd. for C15H20N7O4S
[M + H]+: 394.1292, found 394.1302.
Compound 4e was obtained in 94 % yield (370 mg) according to
the general procedure B (DBU: 152 mg, 1.0 mmol; amidine 1a:
165 mg, 1.0 mmol; azide 2e: 228 mg, 1.0 mmol; 1,4-dioxane (4 mL))
as a light yellow solid; m.p. 258–259 °C.
N-((4Z,5Z)-5-(Amino(pyrrolidin-1-yl)methylene)-3,5-dihydro-4H-
1,2,3-triazol-4-ylidene)fluorobenzenesulfonamide (5a): Com-
pound 5a was obtained in 92 % yield (311 mg) according to the
general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1b:
137 mg, 1.0 mmol; azide 2a: 201 mg, 1.0 mmol; ethanol (4 mL)) as
a colorless solid; m.p. 236–237 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 1.94–1.97 (m, 4H), 3.48–3.52 (m, 2H), 4.06–4.18 (m, 2H), 7.27 (t,
J = 8.0 Hz, 2H), 7.86–7.90 (m, 2H), 8.06 (br. s, 1H), 8.26 (br. s, 1H),
14.20 (br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ = 23.5, 25.5, 48.8,
52.1, 115.4 (d, J = 22 Hz), 118.8, 128.3 (d, J = 9 Hz), 141.1 (d, J =
3 Hz), 146.8, 153.1, 163.2 (d, J = 248 Hz). IR (ATR, ZnSe, cm–1):
ν 3393, 3160, 3078, 2926, 1647, 1602, 1494, 1266, 1215, 1119, 1073,
947. HRMS (ESI-TOF) m/z calcd. for C13H16FN6O2S [M + H]+: 339.1034,
found 339.1044.
Compound 5a was obtained in 88 % yield (267.5 mg) according to
the general procedure C (4-fluorobenzenesulfonyl chloride (2′a):
194 mg, 1.0 mmol; NaN3: 68.3 mg, 1.05 mmol; amidine 1b: 123 mg,
0.9 mmol; Na: 25 mg, 1.08 mmol, EtOH (4 mL)) as a colorless solid;
m.p. 235–237 °C.
N-((4Z,5Z)-5-(Amino(pyrrolidin-1-yl)methylene)-3,5-dihydro-4H-
1,2,3-triazol-4-ylidene)benzenesulfonamide (5b): Compound 5b
was obtained in 94 % yield (301 mg) according to the general pro-
cedure A (sodium: 28 mg, 1.2 mmol; amidine 1b: 137 mg, 1.0 mmol;
azide 2b: 183 mg, 1.0 mmol; ethanol (4 mL)) as a colorless solid,
m.p. 267–268 °C. 1H NMR (400 MHz, [D6]DMSO): δ = 1.95 (t, J =
8.0 Hz, 4H), 3.48–3.51 (m, 2H), 4.06–4.09 (m, 2H), 7.42–7.48 (m, 3H),
7.82–7.84 (m, 2H), 8.04 (br. s, 1H), 9.32 (br. s, 1H), 14.17 (br. s, 1H).
13C NMR (100 MHz, [D6]DMSO): δ = 23.4, 25.4, 48.7, 52.0, 118.6,
125.5, 128.4, 130.7, 144.7, 146.9, 153.1. IR (ATR, ZnSe, cm–1): ν 3452,
3277, 3171, 2966, 1634, 1605, 1219, 1078, 938. HRMS (ESI-TOF) m/z
calcd. for C13H17N6O2S [M + H]+: 321.1128, found 321.1133.
N-((4Z,5Z)-5-(Amino(pyrrolidin-1-yl)methylene)-3,5-dihydro-4H-
1,2,3-triazol-4-ylidene)methylbenzenesulfonamide (5c): Com-
Eur. J. Org. Chem. 2020, 3688–3698 www.eurjoc.org © 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim3694
pound 5c was obtained in 89 % yield (279 mg) according to the
general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1b:
137 mg, 1.0 mmol; azide 2c: 197 mg, 1.0 mmol; ethanol (4 mL)) as
a colorless solid; m.p. 238–239 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 1.91–1.99 (m, 4H), 2.30 (s, 3H), 3.46–3.53 (m, 2H), 4.04–4.11 (m,
2H), 7.24 (d, J = 8.2 Hz, 2H), 7.71 (d, J = 8.2 Hz, 2H), 8.02 (br. s, 1H),
9.33 (br. s, 1H), 14.12 (br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ =
20.7, 23.4, 25.4, 48.7, 52.0, 118.5, 125.6, 128.9, 140.6, 141.9, 147.0,
153.1. IR (ATR, ZnSe, cm–1): ν 3387, 3220, 3103, 3085, 1605, 1550,
1496, 1359, 1266, 1129, 1078, 927. HRMS (ESI-TOF) m/z calcd. for
C14H19N6O2S [M + H]+: 335.1285, found 335.1291.
Compound 5c was obtained in 87 % yield (261 mg) according to
the general procedure C (4-methylbenzenesulfonyl chloride (2′c):
190 mg, 1.0 mmol; NaN3: 68.3 mg, 1.05 mmol; amidine 1b: 123 mg,




pound 5d was obtained in 95 % yield (333 mg) according to the
general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1b:
137 mg, 1.0 mmol; azide 2d: 213 mg, 1.0 mmol; ethanol (4 mL)) as
a colorless solid; m.p. 182–183 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 1.94–1.97 (m, 4H), 3.48–3.51 (m, 2H), 3.77 (s, 3H), 4.06–4.09 (m,
2H), 6.96 (d, J = 9.0 Hz, 2H), 7.77 (d, J = 9.0 Hz, 2H), 8.02 (br. s, 1H),
9.35 (br. s, 1H), 14.10 (br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ =
23.4, 25.4, 48.7, 52.0, 55.3, 113.6, 118.4, 127.5, 136.7, 147.0, 153.1,
170.0. IR (ATR, ZnSe, cm–1): ν 3243, 3157, 3134, 1644, 1598, 1369,
1231, 1123, 1088, 944. HRMS (ESI-TOF) m/z calcd. for C14H19N6O3S
[M + H]+: 351.1234, found 351.1242.
N-((4Z,5Z)-5-(Amino(pyrrolidin-1-yl)methylene)-3,5-dihydro-4H-
1,2,3-triazol-4-ylidene)nitrobenzenesulfonamide (5e): Com-
pound 5e was obtained in 31 % yield (113 mg) according to the
general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1b:
137 mg, 1.0 mmol; azide 2e: 228 mg, 1.0 mmol; ethanol (4 mL)) as
a light yellow solid; m.p. 225–226 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 1.92–2.01 (m, 4H), 3.46–3.51 (m, 2H), 4.01–4.11 (m, 2H), 8.05 (d,
J = 9.0 Hz, 2H), 8.13 (br. s, 1H), 8.28 (d, J = 9.0 Hz, 2H), 9.11 (br. s,
1H), 14.37 (br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ = 23.5, 25.4,
48.8, 52.1, 119.4, 123.9, 127.0, 146.2, 148.6, 150.4, 153.1. IR (ATR,
ZnSe, cm–1): ν 3268, 3132, 2949, 1659, 1609, 1564, 1521, 1345, 1263,
1141, 1090, 966. HRMS (ESI-TOF) m/z calcd. for C13H16N7O4S [M +
H]+: 366.0979, found 366.0989.
Compound 5e was obtained in 95 % yield (348 mg) according to
the general procedure B (DBU: 152 mg, 1.0 mmol; amidine 1b:
137 mg, 1.0 mmol; azide 2e: 228 mg, 1.0 mmol; 1,4-dioxane (4 mL))
as a light yellow solid; m.p. 224–226 °C.
N-((4Z,5Z)-5-(Amino(piperidin-1-yl)methylene)-3,5-dihydro-4H-
1,2,3-triazol-4-ylidene)-4-fluorobenzenesulfonamide (6a): Com-
pound 6a was obtained in 88 % yield (310 mg) according to the
general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1c:
151 mg, 1.0 mmol; azide 2a: 201 mg, 1.0 mmol; ethanol (4 mL)) as
a colorless solid, m.p. 194–195 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 1.56–1.71 (m, 6H), 3.65–3.98 (m, 4H), 7.26 (t, J = 8.9 Hz, 2H),
7.86 (dd, J = 8.9, 5.4 Hz, 2H), 8.39 (br. s, 1H), 9.28 (br. s, 1H), 14.14
(br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ = 20.6, 23.1, 25.4, 48.9,
59.6, 115.3 (d, J = 22 Hz), 118.9, 128.3 (d, J = 9 Hz), 141.3 (d, J =
3 Hz), 146.5, 154.8, 163.1 (d, J = 248 Hz). IR (ATR, ZnSe, cm–1):
ν 3329, 3250, 3178, 2972, 1652, 1603, 1554, 1294, 1189, 1131, 1083,
1083, 946. HRMS (ESI-TOF) m/z calcd. for C14H18FN6O2S [M + H]+:
353.1190, found 353.1200.
N-((4Z,5Z)-5-(Amino(piperidin-1-yl)methylene)-3,5-dihydro-4H-
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was obtained in 92 % yield (274 mg) according to the general pro-
cedure A (sodium: 28 mg, 1.2 mmol; amidine 1c: 151 mg, 1.0 mmol;
azide 2b: 183 mg, 1.0 mmol; ethanol (4 mL)) as a colorless solid;
m.p. 197–198 °C. 1H NMR (400 MHz, [D6]DMSO): δ = 1.57–1.69 (m,
6H), 3.66–4.08 (m, 4H), 7.41–7.47 (m, 3H), 7.81–7.83 (m, 2H), 8.37
(br. s, 1H), 9.35 (br. s, 1H), 14.12 (br. s, 1H). 13C NMR (100 MHz,
[D6]DMSO): δ = 23.1, 25.4, 48.7, 118.7, 125.5, 128.4, 130.6, 144.8,
146.7, 154.8. IR (ATR, ZnSe, cm–1): ν 3269, 3111, 2943, 1655, 1605,
1552, 1495, 1443, 1365, 1127, 1084, 939. HRMS (ESI-TOF) m/z calcd.
for C14H19N6O2S [M + H]+: 335.1285, found 335.1288.
N-((4Z,5Z)-5-(Amino(piperidin-1-yl)methylene)-3,5-dihydro-4H-
1,2,3-triazol-4-ylidene)-4-methylbenzenesulfonamide (6c): Com-
pound 6c was obtained in 87 % yield (303 mg) according to the
general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1c:
151 mg, 1.0 mmol; azide 2c: 197 mg, 1.0 mmol; ethanol (4 mL)) as
a colorless solid; m.p. 217–218 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 1.58–1.69 (m, 6H), 2.31 (s, 3H), 3.63–4.09 (m, 4H), 7.23 (d, J =
8.0 Hz, 2H), 7.71 (d, J = 8.0 Hz, 2H), 8.35 (br. s, 1H), 9.39 (br. s, 1H),
14.06 (br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ = 20.7, 23.1, 25.4,
48.8, 118.5, 125.6, 128.8, 140.5, 142.0, 146.9, 154.8. IR (ATR, ZnSe,
cm–1): ν 3363, 3224, 3048, 2943, 2854, 1662, 1605, 1556, 1487, 1371,
1119, 1084, 948. HRMS (ESI-TOF) m/z calcd. for C15H21N6O2S [M +
H]+: 349.1441, found 349.1447.
N-((4Z,5Z)-5-(Amino(piperidin-1-yl)methylene)-3,5-dihydro-4H-
1,2,3-triazol-4-ylidene)-4-methoxybenzenesulfonamide (6d):
Compound 6d was obtained in 95 % yield (346 mg) according to
the general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1c:
151 mg, 1.0 mmol; azide 2d: 213 mg, 1.0 mmol; ethanol (4 mL)) as
a colorless solid, m.p. 185–186 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 1.59–1.70 (m, 6H), 3.75–4.05 (m, 4H), 3.78 (s, 3H), 6.96 (d, J =
8.0 Hz, 2H), 7.76 (d, J = 8.0 Hz, 2H), 8.34 (br. s, 1H), 9.40 (br. s, 1H),
14.06 (br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ = 23.1, 25.4, 48.7,
55.3, 113.5, 118.3, 127.5, 136.8, 146.9, 154.7, 160.9. HRMS (ESI-TOF)
m/z calcd. for C15H21N6O3S [M + H]+: 365.1390, found 365.1398.
N-((4Z,5Z)-5-(Amino(piperidin-1-yl)methylene)-3,5-dihydro-4H-
1,2,3-triazol-4-ylidene)-4-nitrobenzenesulfonamide (6e): Com-
pound 6e was obtained in 38 % yield (144 mg) according to the
general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1c:
151 mg, 1.0 mmol; azide 2e: 228 mg, 1.0 mmol; ethanol (4 mL)) as
a light yellow solid; m.p. 241–242 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 1.54–1.73 (m, 6H), 3.50–4.10 (m, 4H), 8.02 (d, J = 8.9 Hz, 2H),
8.27 (d, J = 8.9 Hz, 2H), 8.46 (br. s, 1H), 9.09 (br. s, 1H), 14.29 (br. s,
1H). 13C NMR (100 MHz, [D6]DMSO): δ = 23.1, 25.4, 49.4, 119.9, 123.9,
127.0, 145.9, 148.5, 150.9, 155.2. IR (ATR, ZnSe, cm–1): ν 3208, 3099,
3049, 2933, 2853, 1668, 1603, 1559, 1522, 1454, 1344, 1265, 1188,
998. HRMS (ESI-TOF) m/z calcd. for C14H18N7O4S [M + H]+: 380.1135,
found 380.1146.
Compound 6e was obtained in 89 % yield (338 mg) according to
the general procedure B (DBU: 152 mg, 1.0 mmol; amidine 1c:
151 mg, 1.0 mmol; azide 2e: 228 mg, 1.0 mmol; 1,4-dioxane (4 mL))
as a light yellow solid; m.p. 241–243 °C.
N-((4Z,5Z)-5-(Amino(4-benzylpiperidin-1-yl)methylene)-3,5-di-
hydro-4H-1,2,3-triazol-4-ylidene)fluorobenzenesulfonamide
(7a): Compound 7a was obtained in 83 % yield (368 mg) according
to the general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1d:
241 mg, 1.0 mmol; azide 2a: 201 mg, 1.0 mmol; ethanol (8 mL)) as
a colorless solid, m.p. 175–176 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 1.20–1.35 (m, 2H), 1.60–1.74 (m, 2H), 1.89 (m, 1H), 2.50–2.57 (m,
2H), 3.10–3.26 (m, 2H), 4.02 (br. s, 1H), 4.90 (br. s, 1H), 7.13–7.22 (m,
3H), 7.22–7.32 (m, 4H), 7.87 (dd, J = 8.4, 5.7 Hz, 2H), 8.45 (br. s, 1H),
9.29 (br. s, 1H), 14.21 (br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ =
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31.4, 36.5, 41.6, 46.5, 49.5, 115.4 (d, J = 22 Hz), 118.9, 125.9, 128.2,
128.4 (d, J = 9 Hz), 129.0, 139.8, 141.3 (d, J = 3 Hz), 146.5, 154.9,
163.2 (d, J = 248 Hz). IR (ATR, ZnSe, cm–1): ν 3356, 3160, 3059, 2926,
1651, 1594, 1556, 1494, 1133, 1087, 953. HRMS (ESI-TOF) m/z calcd.
for C21H24FN6O2S [M + H]+: 443.1660, found 443.1673.
N-((4Z,5Z)-5-(Amino(4-benzylpiperidin-1-yl)methylene)-3,5-di-
hydro-4H-1,2,3-triazol-4-ylidene)benzenesulfonamide (7b):
Compound 7b was obtained in 76 % yield (323 mg) according to
the general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1d:
241 mg, 1.0 mmol; azide 2b: 183 mg, 1.0 mmol; ethanol (8 mL)) as
a colorless solid; m.p. 128–129 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 1.24–1.34 (m, 2H), 1.67–1.70 (m, 2H), 1.83–1.98 (m, 1H), 2.53–
2.54 (m, 2H), 3.19 (t, J = 12 Hz, 2H), 4.44 (br. s, 2H), 7.16–7.20 (m,
3H), 7.27–7.30 (m, 2H), 7.43–7.45 (m, 3H), 7.82–7.84 (m, 2H), 8.38
(br. s, 1H), 9.37 (br. s, 1H), 14.12 (br. s, 1H). 13C NMR (100 MHz,
[D6]DMSO): δ = 31.3, 36.4, 41.5, 48.0, 118.6, 125.5, 125.8, 128.1,
128.4, 128.9, 130.6, 139.7, 144.8, 146.9, 154.8. IR (ATR, ZnSe, cm–1):
ν 3247, 3169, 2913, 1653, 1601, 1556, 1138, 1087, 945. HRMS (ESI-
TOF) m/z calcd. for C22H27N6O2S [M + H]+: 439.1911, found 439.1917.
N-((4Z,5Z)-5-(Amino(4-benzylpiperidin-1-yl)methylene)-3,5-di-
hydro-4H-1,2,3-triazol-4-ylidene)methylbenzenesulfonamide
(7c): Compound 7c was obtained in 74 % yield (325 mg) according
to the general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1d:
241 mg, 1.0 mmol; azide 2c: 197 mg, 1.0 mmol; ethanol (8 mL)) as
a colorless solid; m.p. 186–187 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 1.23–1.33 (m, 2H), 1.65–1.68 (m, 2H), 1.82–1.96 (m, 1H), 2.30 (s,
3H), 2.53 (d, J = 8.0 Hz, 2H), 3.14–3.20 (m, 2H), 4.03 (br. s, 1H), 4.97
(br. s, 1H), 7.16–7.30 (m, 7H), 7.70 (d, J = 8.0 Hz, 2H), 8.40 (br. s, 1H),
9.37 (br. s, 1H), 14.14 (br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ =
20.8, 31.4, 36.6, 41.7, 46.5, 49.6, 118.6, 125.7, 126.0, 128.2, 128.9,
129.0, 139.9, 140.7, 142.0, 146.8, 154.8. IR (ATR, ZnSe, cm–1): ν 3300,
3261, 3167, 2924, 2852, 1651, 1600, 1555, 1494, 1132, 1084, 941.




(7d): Compound 7d was obtained in 81 % yield (369 mg) according
to the general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1d:
241 mg, 1.0 mmol; azide 2d: 213 mg, 1.0 mmol; ethanol (8 mL)) as
a colorless solid; m.p. 126–127 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 1.23–1.32 (m, 2H), 1.66–1.69 (m, 2H), 1.82–1.97 (m, 1H), 2.53 (d,
J = 8.0 Hz, 2H), 3.10–3.25 (m, 2H), 3.76 (s, 3H), 4.03 (br. s, 1H), 5.01
(br. s, 1H), 6.96 (d, J = 8.7 Hz, 2H), 7.16–7.20 (m, 3H), 7.26–7.30 (m,
2H), 7.74 (d, J = 8.7 Hz, 2H), 8.43 (br. s, 1H), 9.42 (br. s, 1H), 14.14
(br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ = 31.5, 36.6, 41.6, 46.8,
49.3, 55.4, 113.6, 118.4, 125.9, 127.6, 128.2, 129.0, 136.8, 139.8, 146.9,
154.8, 161.0. IR (ATR, ZnSe, cm–1): ν 3302, 3226, 3094, 2921, 2838,
1661, 1595, 1543, 1495, 1171, 1133, 1054, 1024, 938. HRMS (ESI-
TOF) m/z calcd. for C22H27N6O3S [M + H]+: 455.1860, found 455.1871.
N-((4Z,5Z)-5-(amino(4-benzylpiperidin-1-yl)methylene)-3,5-di-
hydro-4H-1,2,3-triazol-4-ylidene)-4-nitrobenzenesulfonamide
(7e): Compound 7e was obtained in 79 % yield (186 mg) according
to the general procedure B (DBU: 76 mg, 0.5 mmol; amidine 1d:
120 mg, 0.5 mmol; azide 2e: 114 mg, 0.5 mmol; 1,4-dioxane (2 mL))
as a light yellow solid, m.p. 219–220 °C. 1H NMR (400 MHz,
[D6]DMSO): δ = 1.20–1.35 (m, 2H), 1.62–1.72 (m, 2H), 1.85–1.95 (m,
1H), 2.54–2.58 (m, 2H), 3.1–3.23 (m, 2H), 4.08 (br. s, 1H), 4.57 (br. s,
1H), 7.14–7.22 (m, 3H), 7.25–7.32 (m, 2H), 8.01 (d, J = 9.0 Hz, 2H),
8.26 (d, J = 9.0 Hz, 2H), 8.48 (br. s, 1H), 9.09 (br. s, 1H), 14.30 (br. s,
1H). 13C NMR (100 MHz, [D6]DMSO): δ = 31.3, 36.3, 41.5, 46.9, 49.5,
119.8, 123.8, 125.8, 126.9, 128.1, 128.9, 139.7, 145.8, 148.4, 150.8,
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pound 8a was obtained in 91 % yield (322 mg) according to the
general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1e:
153 mg, 1.0 mmol; azide 2a: 201 mg, 1.0 mmol; ethanol (4 mL)) as
a colorless solid; m.p. 224–225 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 3.73–4.02 (m, 8H), 7.27 (t, J = 8.0 Hz, 2H), 7.88 (dd, J = 8.0,
4.0 Hz, 2H), 8.54 (br. s, 1H), 9.44 (br. s, 1H), 14.19 (br. s, 1H). 13C NMR
(100 MHz, [D6]DMSO): δ = 48.0, 65.5, 115.3 (d, J = 22 Hz), 118.6,
128.4 (d, J = 9 Hz), 141.2 (d, J = 3 Hz), 146.8, 155.5, 163.1 (d, J =
248 Hz). IR (ATR, ZnSe, cm–1): ν 3301, 3210, 3107, 3049, 2930, 2838,
1657, 1588, 1547, 1489, 1174, 1104, 1082, 831. HRMS (ESI-TOF) m/z
calcd. for C13H16FN6O3S [M + H]+: 355.0983, found 355.0984.
Compound 8a was obtained in 85 % yield (271 mg) according to
the general procedure C (4-fluorobenzenesulfonyl chloride (2′a):
194 mg, 1.0 mmol; NaN3: 68.3 mg, 1.05 mmol; amidine 1e:
137.7 mg, 0.9 mmol; Na: 25 mg, 1.08 mmol, EtOH (4 mL)) as a
colorless solid; m.p. 223–226 °C.
N-((4Z,5Z)-5-(Amino(morpholino)methylene)-3,5-dihydro-4H-
1,2,3-triazol-4-ylidene)benzenesulfonamide (8b): Compound 8b
was obtained in 93 % (313 mg) according to the general procedure
A (sodium: 28 mg, 1.2 mmol; amidine 1e: 153 mg, 1.0 mmol; azide
2b: 183 mg, 1.0 mmol; ethanol (4 mL)) as a colorless solid m.p. 196–
197 °C. 1H NMR (400 MHz, [D6]DMSO): δ = 3.60–4.22 (m, 8H), 7.44–
7.46 (m, 3H), 7.82–7.84 (m, 2H), 8.55 (br. s, 1H), 9.49 (br. s, 1H), 14.24
(br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ = 47.9, 65.6, 118.5,
125.6, 128.6, 130.8, 144.7, 147.0, 155.5. IR (ATR, ZnSe, cm–1): ν 3319,
3164, 2956, 2868, 1651, 1577, 1550, 1175, 1140, 1081, 1007, 949.




pound 8c was obtained in 90 % yield (315 mg) according to the
general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1e:
153 mg, 1.0 mmol; azide 2c: 197 mg, 1.0 mmol; ethanol (4 mL)) as
a colorless solid; m.p. 219–220 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 2.32 (s, 3H), 3.69–4.16 (m, 8H), 7.24 (d, J = 8.0 Hz, 2H), 7.71 (d,
J = 8.0 Hz, 2H), 8.49 (br. s, 1H), 9.53 (br. s, 1H), 14.12 (br. s, 1H). 13C
NMR (100 MHz, [D6]DMSO): δ = 20.7, 47.9, 65.5, 118.2, 125.6, 128.8,
140.6, 141.9, 147.0, 155.5. IR (ATR, ZnSe, cm–1): ν 3304, 3223, 3142,
2913, 2864, 1658, 1592, 1546, 1493, 1232, 1171, 1106, 1086, 938.
HRMS (ESI-TOF) m/z calcd. for C14H19N6O3S [M + H]+: 351.1234,
found 351.1236.
Compound 8c was obtained in 88 % yield (277.5 mg) according to
the general procedure C (4-methylbenzenesulfonyl chloride (2′c):
190 mg, 1.0 mmol; NaN3: 68.3 mg, 1.05 mmol; amidine 1e:
137.7 mg, 0.9 mmol; Na: 25 mg, 1.08 mmol, EtOH (4 mL)) as a
colorless solid; m.p. 219–221 °C.
N-((4Z,5Z)-5-(Amino(morpholino)methylene)-3,5-dihydro-4H-
1,2,3-triazol-4-ylidene)-4-methoxybenzenesulfonamide (8d):
Compound 8d was obtained in 86 % yield (315 mg) according to
the general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1e:
153 mg, 1.0 mmol; azide 2d: 213 mg, 1.0 mmol; ethanol (4 mL)) as
a colorless solid; m.p. 205–206 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 3.73–3.74 (m, 4H), 3.78 (s, 3H), 3.80–4.15 (m, 4H), 6.97 (d, J =
12.0 Hz, 2H), 7.76 (d, J = 12.0 Hz, 2H), 8.48 (br. s, 1H), 9.56 (br. s,
1H), 14.11 (br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ = 48.0, 55.3,
65.6, 113.6, 118.1, 127.5, 136.7, 147.0, 155.4, 161.0. IR (ATR, ZnSe,
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cm–1): ν 3269, 3150, 2964, 2904, 2816, 1653, 1590, 1172, 1107, 1083,




pound 8e was obtained in 34 % yield (129 mg) according to the
general procedure A (sodium: 28 mg, 1.2 mmol; amidine 1e:
153 mg, 1.0 mmol; azide 2e: 228 mg, 1.0 mmol; ethanol (4 mL)) as
a light yellow solid; m.p. 252–253 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 3.74–3.95 (m, 8H), 8.03 (d, J = 9.0 Hz, 2H), 8.27 (d, J = 9.0 Hz, 2H),
8.61 (br. s, 1H), 9.27 (br. s, 1H), 14.34 (br. s, 1H). 13C NMR (100 MHz,
[D6]DMSO): δ = 48.0, 65.5, 119.5, 125.9, 127.0, 146.1, 148.5, 150.7,
155.8. IR (ATR, ZnSe, cm–1): ν 3316, 3240, 3150, 3034, 1662, 1592,
1566, 1510, 1306, 1228, 1187, 1088, 950, 856. HRMS (ESI-TOF) m/z
calcd. for C13H16N7O5S [M + H]+: 382.0928, found 382.0935.
Compound 8e was obtained in 76 % yield (290 mg) according to
the general procedure B (DBU: 152 mg, 1.0 mmol; amidine 1e:
153 mg, 1.0 mmol; azide 2e: 228 mg, 1.0 mmol; 1,4-dioxane (4 mL))
as a light yellow solid; m.p. 250–253 °C.
N-((4Z,5Z)-5-(Amino(pyrrolidin-1-yl)methylene)-3,5-dihydro-4H-
1,2,3-triazol-4-ylidene)methanesulfonamide (9): Compound 9
was obtained in 59 % yield (152 mg) according to the general pro-
cedure A (sodium: 28 mg, 1.2 mmol; amidine 1b: 137 mg, 1.0 mmol;
azide 2f: 121 mg, 1.0 mmol; ethanol (4 mL)) as a colorless solid,
m.p. 256–257 °C. 1H NMR (400 MHz, [D6]DMSO): δ = 1.91–2.04 (m,
4H), 2.81 (s, 3H), 3.51 (br. s, 2H), 4.11 (br. s, 2H), 8.07 (br. s, 1H), 9.32
(br. s, 1H), 14.16 (br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ = 23.6,
25.6, 40.5, 48.6, 52.1, 117.9, 147.5, 153.2. IR (ATR, ZnSe, cm–1):
ν 3333, 3254, 3135, 2958, 1633, 1594, 1566, 1325, 1221, 1094, 965.
HRMS (ESI-TOF) m/z calcd. for C8H15N6O2S [M + H]+: 259.0972, found
259.0979.
N-((4Z,5Z)-5-(Amino(piperidin-1-yl)methylene)-3,5-dihydro-4H-
1,2,3-triazol-4-ylidene)methanesulfonamide (10): Compound 10
was obtained in 50 % yield (136 mg) according to the general pro-
cedure A (sodium: 28 mg, 1.2 mmol; amidine 1c: 151 mg, 1.0 mmol;
azide 2f: 121 mg, 1.0 mmol; ethanol (4 mL)) as a colorless solid,
m.p. 216–217 °C. 1H NMR (400 MHz, [D6]DMSO): δ = 1.60–1.75 (m,
6H), 2.82 (s, 3H), 3.80–4.10 (m, 4H), 8.33 (br. s, 1H), 9.42 (br. s, 1H),
13.85 (br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ = 23.1, 25.4, 40.6,
48.7, 117.9, 147.4, 154.8. IR (ATR, ZnSe, cm–1): ν 3326, 3260, 3148,
3084, 2927, 1656, 1595, 1572, 1243, 1109, 951. HRMS (ESI-TOF) m/z
calcd. for C9H17N6O2S: [M + H]+: 273.1128, found 273.1136.
N-((4Z,5Z)-5-(Amino(azepane-1-yl)methylene)-3,5-dihydro-4H-
1,2,3-triazol-4-ylidene)methanesulfonamide (11): Compound 11
was obtained in 66 % yield (189 mg) according to the general pro-
cedure A (sodium: 28 mg, 1.2 mmol; amidine 1a: 165 mg, 1.0 mmol;
azide 2f: 121 mg, 1.0 mmol; ethanol (4 mL)) as a colorless solid,
m.p. 242–243 °C. 1H NMR (400 MHz, [D6]DMSO): δ = 1.47–1.61 (m,
4H), 1.73–1.87 (m, 4H), 2.83 (s, 3H), 3.55–3.72 (m, 2H), 4.21–4.38 (m,
2H), 8.17 (br. s, 1H), 9.67 (br. s, 1H), 14.12 (br. s, 1H). 13C NMR
(100 MHz, [D6]DMSO): δ = 25.2, 25.8, 26.0, 28.4, 40.5, 50.1, 51.8,
117.6, 147.7, 155.1. IR (ATR, ZnSe, cm–1): ν 3311, 3257, 3173, 3093,
2924, 2866, 1650, 1603, 1572, 1109, 974. HRMS (ESI-TOF) m/z calcd.
for C10H19N6O2S: [M + H]+: 287.1285, found 287.1294.
Compound 11 was obtained in 76 % yield (218 mg) according to
the general procedure B (DBU: 152 mg, 1.0 mmol; amidine 1a:
165 mg, 1.0 mmol; azide 2f: 121 mg, 1.0 mmol; 1,4-dioxane (4 mL))
as a colorless solid, m.p. 242–243 °C.
N-((4Z,5Z)-5-(Amino(morpholino)methylene)-3,5-dihydro-4H-
1,2,3-triazol-4-ylidene)methanesulfonamide (12): Compound 12
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cedure A (sodium: 28 mg, 1.2 mmol; amidine 1e: 153 mg, 1.0 mmol;
azide 2f: 121 mg, 1.0 mmol; ethanol (4 mL)) as a colorless solid,
m.p. 221–222 °C. 1H NMR (400 MHz, [D6]DMSO): δ = 2.82 (s, 3H),
3.76–3.79 (m, 4H), 3.87–4.15 (m, 4H), 8.48 (br. s, 1H), 9.55 (br. s, 1H),
13.97 (br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ = 40.6, 48.1, 65.6,
117.7, 147.6, 155.4. IR (ATR, ZnSe, cm–1): ν 3245, 3028, 2861, 1654,
1566, 1183, 1100, 957. HRMS (ESI-TOF) m/z calcd. for C8H15N6O3S
[M + H]+: 275.0921, found 275.0926.
N-((4Z,5Z)-5-(amino(4-benzylpiperidin-1-yl)methylene)-3,5-di-
hydro-4H-1,2,3-triazol-4-ylidene)methanesulfonamide (13):
Compound 13 was obtained in 68 % yield (123 mg) according to
the general procedure B (DBU: 76 mg, 0.5 mmol; amidine 1d:
120 mg, 0.5 mmol; azide 2f: 67 mg, 0.55 mmol; 1,4-dioxane (2 mL))
as a colorless solid, m.p. 204–205 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 1.25–1.38 (m, 2H), 1.69–1.77 (m, 2H), 1.85–2.00 (m, 1H), 2.55–
2.57 (m, 2H), 2.81 (s, 3H), 3.21–3.25 (m, 2H), 4.62 (br. s, 2H), 7.16–
7.22 (m, 3H), 7.27–7.32 (m, 2H), 8.36 (br. s, 1H), 9.42 (br. s, 1H), 13.95
(br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ = 31.5, 36.5, 40.6, 41.6,
47.9, 117.8, 125.8, 128.1, 128.9, 139.7, 147.4, 154.7. IR (ATR, ZnSe,
cm–1): ν 3103, 2920, 2852, 2725, 1661, 1601, 1462, 1377, 1257, 1112,




Compound 14a was obtained in 72 % yield (221 mg) according to
the general procedure B (DBU: 152 mg, 1.0 mmol; amidine 1f:
111 mg, 1.0 mmol; azide 2c: 197 mg, 1.0 mmol; 1,4-dioxane (3 mL))
as a colorless solid, m.p. 232–233 °C. 1H NMR (400 MHz, [D6]DMSO):
δ = 2.30 (s, 3H), 3.15 (br.s, 3H), 3.56 (br. s, 3H), 7.23 (d, J = 8.0 Hz,
2H), 7.71 (d, J = 8.0 Hz, 2H), 8.15 (br. s, 1H), 9.46 (br. s, 1H), 14.10
(br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ = 20.7, 39.6 (from
HSQC), 42.3, 118.5, 125.6, 128.8, 140.6, 141.9, 146.9, 156.0. IR (ATR,
ZnSe, cm–1): ν 3592, 3455, 3327, 3113, 1659, 1632, 1556, 1496, 1461,
1377, 1254, 1138, 1085, 1062, 1036, 1021. HRMS (ESI-TOF) m/z calcd.
for C12H16N6O2S [M + H]+: 309.1128, found 309.1137.
N-((4Z,5Z)-5-(Amino(dimethylamino)methylene)-3,5-dihydro-
4H-1,2,3-triazol-4-ylidene)-4-methoxybenzenesulfonamide
(14b): Compound 14b was obtained in 84 % yield (272 mg) accord-
ing to the general procedure B (DBU: 152 mg, 1.0 mmol; amidine
1f: 111 mg, 1.0 mmol; azide 2d: 213 mg, 1.0 mmol; 1,4-dioxane
(3 mL)) as a colorless solid, m.p. 130–131 °C. 1H NMR (400 MHz,
[D6]DMSO): δ = 3.16 (br.s, 3H), 3.56 (br.s, 3H), 3.78 (s, 3H), 6.96 (d,
J = 8.8 Hz, 2H), 7.75 (d, J = 8.8 Hz, 2H), 8.15 (br. s, 1H), 9.47 (br. s,
1H), 14.08 (br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ = 39.5 (from
HSQC), 42.2, 55.3, 113.6, 118.4, 127.5, 136.7, 147.0, 156.0, 160.9. IR
(ATR, ZnSe, cm–1): ν 3571, 3437, 3327, 3259, 3096, 1656, 1631, 1594,
1576, 1557, 1499, 1466, 1437, 1376, 1310, 1254, 1181, 1137, 1089,
1063, 1033, 1016. HRMS (ESI-TOF) m/z calcd. for C12H16N6O3S [M +
H]+: 325.1077, found 325.1085.
N-((4Z,5Z)-5-(Amino(dimethylamino)methylene)-3,5-dihydro-
4H-1,2,3-triazol-4-ylidene)methanesulfonamide (14c): Com-
pound 14c was obtained in 70 % yield (326 mg) according to the
general procedure B (DBU: 304 mg, 2.0 mmol; amidine 1f: 222 mg,
2.0 mmol; azide 2f: 242 mg, 2.0 mmol; 1,4-dioxane (6 mL)) as a
colorless solid, m.p. 235–236 °C. 1H NMR (400 MHz, [D6]DMSO): δ =
2.81 (s, 3H), 3.24 (br.s, 3H), 3.58 (br.s, 3H), 8.15 (br. s, 1H), 9.46 (br. s,
1H), 14.02 (br. s, 1H). 13C NMR (100 MHz, [D6]DMSO): δ = 39.4 (from
HSQC), 40.6, 42.2, 118.0, 147.5, 156.0. IR (ATR, ZnSe, cm–1): ν 3317,
3244, 3159, 3116, 3028, 1650, 1631, 1571, 1463, 1417, 1377, 1334,
1255, 1234, 1165, 1115, 1062, 1040. HRMS (ESI-TOF) m/z calcd. for
C6H12N6O2S [M + H]+: 233.0815, found 233.0814.
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X-ray structural analysis of compounds 4c, 5b, and 7c were per-
formed on an Xcalibur Ruby diffractometer using Mo X-ray source
(Mo-Kα 0.71073 Å), scanning at 295(2) K. The structures were solved
by the SHELXS software and refined by full-matrix least-squares on
all F2 data using SHELXL-97[25] in conjunction with the WinGX
graphical user interface.[26]
Deposition Number(s) (CCDC 1959386 (4c), 1959374 (5b), 1959375
(7c)). contain(s) the supplementary crystallographic data for this pa-
per. These data are provided free of charge by the joint Cambridge
Crystallographic Data Centre and Fachinformationszentrum Karls-
ruhe Access Structures service www.ccdc.cam.ac.uk/structures.
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